| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.19B | 6.96B | 6.92B | 6.47B | 5.03B |
| Gross Profit | 1.13B | 1.03B | 1.04B | 936.20M | 860.20M |
| EBITDA | 352.20M | 268.20M | 363.00M | 349.70M | 346.20M |
| Net Income | 153.70M | 170.80M | 197.60M | 182.80M | 185.30M |
Balance Sheet | |||||
| Total Assets | 4.06B | 3.37B | 3.06B | 3.28B | 2.71B |
| Cash, Cash Equivalents and Short-Term Investments | 628.50M | 489.60M | 471.20M | 275.10M | 285.20M |
| Total Debt | 202.30M | 136.90M | 127.60M | 157.90M | 189.90M |
| Total Liabilities | 3.17B | 2.55B | 2.11B | 2.41B | 1.97B |
| Stockholders Equity | 897.90M | 810.20M | 941.70M | 865.70M | 740.50M |
Cash Flow | |||||
| Free Cash Flow | 273.80M | 398.10M | 375.50M | 206.10M | 192.00M |
| Operating Cash Flow | 295.60M | 417.10M | 410.60M | 241.60M | 222.30M |
| Investing Cash Flow | -37.60M | -38.20M | -39.40M | -62.70M | -25.30M |
| Financing Cash Flow | -122.20M | -349.40M | -163.60M | -180.50M | -226.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.36B | 10.91 | 42.93% | 2.05% | 51.50% | 11.62% | |
72 Outperform | £50.55M | 14.63 | 38.65% | 2.69% | 30.01% | 138.65% | |
69 Neutral | £57.48M | 15.19 | 12.27% | ― | 20.40% | ― | |
68 Neutral | £3.24B | 20.00 | 17.42% | 2.43% | 21.86% | 0.86% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £187.99M | 18.70 | 4.57% | 3.01% | -31.46% | 297.44% | |
52 Neutral | £29.55M | -2.77 | -18.74% | ― | -5.84% | 55.30% |